Product Code: PM4294
The global inhalation anesthesia market size is expected to reach USD 3.42 billion by 2032, according to a new study by Polaris Market Research. The report "Inhalation Anesthesia Market Share, Size, Trends, Industry Analysis Report, By Drug (Sevoflurane, Desflurane, Isoflurane, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of minimally invasive surgeries, driven by their effectiveness in reducing hospitalization durations, contributes to market growth. These procedures are known to reduce post-operative pain, resulting in less reliance on painkillers with lower dosage requirements for patients.
Furthermore, because fewer cuts or stitches are required, the hospitalization duration is comparatively shorter, and patients are not required to return to the hospital on a regular basis. According to Becker's Spine Review data, over 160 Ambulatory Surgical Centers (ASCs) in the United States are performing minimally invasive spine surgeries as of December 2020, representing a significant increase over the last decade.
The increase in emergency and trauma cases, combined with patients' increasing preference for ambulatory day care procedures, will have a positive impact on the expansion of the inhalation anesthesia market.
The rising prevalence of diseases such as cardiac disease, neurovascular disease, and other chronic conditions will increase the demand for a wide range of surgical interventions. According to the Centers for Disease Control and Prevention, over 730,000 Americans have a heart attack each year, highlighting the growing demand for medical procedures.
The market for inhalation anesthetics faces challenges such as lower adoption rates in specific surgical procedures, widespread generic competition for nearly all halogenated agents, and recent patent expirations, which hamper on market growth.
Anesthesia machine manufacturers have focused on incorporating features such as electronic vaporizers, advanced monitoring capabilities, and ergonomic designs to improve patient safety and overall workflow in healthcare settings. Furthermore, there has been a growing emphasis on the development of inhalation anesthetics with improved pharmacokinetic profiles and lower environmental impact. The market has witnessed a growing partnership between pharmaceutical companies and healthcare providers to streamline anesthesia management protocols and ensure optimal patient outcomes.
Inhalation Anesthesia Market Report Highlights
In 2023, the sevoflurane segment accounted for the largest revenue share in the inhalation anesthesia market, because of its therapeutic properties, sevoflurane is a commonly used anesthetic. It is an inhalation anesthetic in the ether class with a non-irritating aroma, low pungency, and a low blood gas partition coefficient.
The hospital segment accounted for the highest market share during the forecast period, owing to the increasing demand for numerous surgical procedures due to the supportive reimbursement policies for the surgeries being performed in the hospital.
In 2023, North America accounted for the largest market share in the inhalation anesthesia market, owing to the increasing prevalence of chronic diseases due to unhealthy dietary habit and sedentary lifestyle changes will facilitate the market's growth.
Asia Pacific region witnessed for the fastest growth in the inhalation anesthesia market due to the surging awareness regarding to the health issue and the increasing expenditure on healthcare in the region. Existence of a large number of patients who choose various surgical interventions will drive the market's growth in the region.
The global key market players include AbbVie Inc., Baxter International Inc., Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC), Fresenius Kabi AG (Fresenius SE & Co. KGaA), Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd, Lunan Pharmaceutical Group Co. Ltd, Merck KGaA, Piramal Enterprises Limited, and Troikaa Pharmaceuticals Ltd.
Polaris Market Research has segmented the inhalation anesthesia market report based on drug, application, end-use, and region:
Inhalation Anesthesia, Drug Outlook (Revenue - USD Billion, 2019 - 2032)
- Sevoflurane
- Desflurane
- Isoflurane
- Others
Inhalation Anesthesia, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Inhalation Anesthesia, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals
- Ambulatory Surgical Centers
- Others
Inhalation Anesthesia, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Inhalation Anesthesia Market Insights
- 4.1. Inhalation Anesthesia Market - End-Use Snapshot
- 4.2. Inhalation Anesthesia Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing number of surgeries will drive the growth of the market
- 4.2.1.2. Rise in the number of emergency cases will bolster the growth of the market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Side effects and complications associated with anaesthetics hindering the market growth
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Inhalation Anesthesia Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Inhalation Anesthesia Market, by Drug
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 5.3. Sevoflurane
- 5.3.1. Global Inhalation Anesthesia Market, by Sevoflurane, by Region, 2019-2032 (USD Billion)
- 5.4. Desflurane
- 5.4.1. Global Inhalation Anesthesia Market, by Desflurane, by Region, 2019-2032 (USD Billion)
- 5.5. Isoflurane
- 5.5.1. Global Inhalation Anesthesia Market, by Isoflurane, by Region, 2019-2032 (USD Billion)
- 5.6. Others
- 5.6.1. Global Inhalation Anesthesia Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Inhalation Anesthesia Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 6.3. Induction
- 6.3.1. Global Inhalation Anesthesia Market, by Induction, by Region, 2019-2032 (USD Billion)
- 6.4. Maintenance
- 6.4.1. Global Inhalation Anesthesia Market, by Maintenance, by Region, 2019-2032 (USD Billion)
7. Global Inhalation Anesthesia Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Inhalation Anesthesia Market, by Hospitals, By Region, 2019-2032 (USD Billion)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. Global Inhalation Anesthesia Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Billion)
- 7.5. Others
- 7.5.1. Global Inhalation Anesthesia Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Inhalation Anesthesia Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Inhalation Anesthesia Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Inhalation Anesthesia Market - North America
- 8.3.1. North America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.3.2. North America: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.3. North America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Inhalation Anesthesia Market - U.S.
- 8.3.4.1. U.S.: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Inhalation Anesthesia Market - Canada
- 8.3.5.1. Canada: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4. Inhalation Anesthesia Market - Europe
- 8.4.1. Europe: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.3. Europe: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Inhalation Anesthesia Market - UK
- 8.4.4.1. UK: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Inhalation Anesthesia Market - France
- 8.4.5.1. France: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.5.3. France: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Inhalation Anesthesia Market - Germany
- 8.4.6.1. Germany: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Inhalation Anesthesia Market - Italy
- 8.4.7.1. Italy: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Inhalation Anesthesia Market - Spain
- 8.4.8.1. Spain: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Inhalation Anesthesia Market - Netherlands
- 8.4.9.1. Netherlands: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Inhalation Anesthesia Market - Russia
- 8.4.10.1. Russia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5. Inhalation Anesthesia Market - Asia Pacific
- 8.5.1. Asia Pacific: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Inhalation Anesthesia Market - China
- 8.5.4.1. China: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.4.3. China: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Inhalation Anesthesia Market - India
- 8.5.5.1. India: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.5.3. India: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Inhalation Anesthesia Market - Malaysia
- 8.5.6.1. Malaysia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Inhalation Anesthesia Market - Japan
- 8.5.7.1. Japan: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Inhalation Anesthesia Market - Indonesia
- 8.5.8.1. Indonesia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Inhalation Anesthesia Market - South Korea
- 8.5.9.1. South Korea: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.6. Inhalation Anesthesia Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Inhalation Anesthesia Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Inhalation Anesthesia Market - UAE
- 8.6.5.1. UAE: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Inhalation Anesthesia Market - Israel
- 8.6.6.1. Israel: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Inhalation Anesthesia Market - South Africa
- 8.6.7.1. South Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.7. Inhalation Anesthesia Market - Latin America
- 8.7.1. Latin America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Inhalation Anesthesia Market - Mexico
- 8.7.4.1. Mexico: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Inhalation Anesthesia Market - Brazil
- 8.7.5.1. Brazil: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Inhalation Anesthesia Market - Argentina
- 8.7.6.1. Argentina: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AbbVie Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Baxter International Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Fresenius Kabi AG (Fresenius SE & Co. KGaA)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Hikma Pharmaceuticals PLC
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Jiangsu Hengrui Medicine Co. Ltd
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Lunan Pharmaceutical Group Co. Ltd
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Merck KGaA
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Piramal Enterprises Limited
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Troikaa Pharmaceuticals Ltd
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development